Athira Pharma, Inc. (ATHA) Misses Q1 EPS by 5c

Athira Pharma, Inc. (NASDAQ: ATHA) reported Q1 EPS of ($0.23), $0.05 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Athira Pharma, Inc. (ATHA) click here.

You May Also Be Interested In

• Science Applications Int'l (SAIC) Tops Q2 EPS by 70c
• PG&E Corporation (PCG) Reiterated at Buy by UBS as Capital Reallocation Expected
• Gap (GAP) Reiterated at Buy by UBS as EPS Growth Rate Expected to Inflect Positiively